HPQ Stock Analysis: HP | NYSE
Computer Hardware | NYSE, USA | Market Cap: 26.720m USD | 12M Return: 13.2% | US40434L1052 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 404M
EPS Trend: -27.3%
Qual. Beats: 3
Rev. Trend: 89.4%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HP Inc. (NYSE: HPQ) is a global provider of personal computing, printing, and 3D printing technologies, operating through three segments: Personal Systems, Printing, and Corporate Investments. The Personal Systems segment supplies commercial and consumer desktops, notebooks, workstations, displays, and related hardware, software, and lifecycle services. The Printing segment offers consumer and commercial printer hardware, supplies, and solutions, including graphics, 3D printing, and personalization offerings for commercial and industrial markets. The Corporate Investments segment focuses on business incubation and investment projects. The company serves small- and medium-sized businesses, public sector, and enterprise customers worldwide, and is headquartered in Palo Alto, California, having been founded in 1939 and renamed from Hewlett-Packard Company in October 2015.
HPQ is classified within the Information Technology sector, specifically the Technology Hardware, Storage & Peripherals sub-industry, a segment that traditionally competes with major rivals like Dell and Lenovo in personal computing and with companies such as Canon and Epson in printing. A notable feature of HPs business model is its dual revenue stream combining lower-margin hardware sales (PCs and printers) with higher-margin recurring revenue from consumables such as ink and toner, which is a characteristic of the printer market that helps stabilize cash flow over equipment lifecycles.
- PC revenue grows on AI PC refresh cycle and Windows 11 migration
- Printing supplies margins pressured by secular office printing decline
- Aggressive share buybacks and dividends support earnings per share growth
| Net Income: 2.45b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.36 > 1.0 |
| NWC/Revenue: -12.20% < 20% (prev -13.32%; Δ 1.13% < -1%) |
| CFO/TA 0.10 > 3% & CFO 4.67b > Net Income 2.45b |
| Net Debt (6.19b) to EBITDA (4.25b): 1.45 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (927.0m) vs 12m ago -2.83% < -2% |
| Gross Margin: 19.87% > 18% (prev 20.89%; Δ -1.02% > 0.5%) |
| Asset Turnover: 138.3% > 50% (prev 137.3%; Δ 1.02% > 0%) |
| Interest Coverage Ratio: 6.60 > 6 (EBIT TTM 3.34b / Interest Expense TTM 506.0m) |
| A: -0.16 (Total Current Assets 26.7b - Total Current Liabilities 34.0b) / Total Assets 45.7b |
| B: -0.04 (Retained Earnings -2.03b / Total Assets 45.7b) |
| C: 0.08 (EBIT TTM 3.34b / Avg Total Assets 42.8b) |
| D: 0.09 (Book Value of Equity 3.87b / Total Liabilities 41.8b) |
| Altman-Z'' = -0.56 = B |
| DSRI: 0.86 (Receivables 7.17b/7.72b, Revenue 59.2b/54.7b) |
| GMI: 1.05 (GM 20.89% / 19.87%) |
| AQI: 0.91 (AQ_t 0.35 / AQ_t-1 0.38) |
| SGI: 1.08 (Revenue 59.2b / 54.7b) |
| TATA: -0.05 (NI 2.45b - CFO 4.67b) / TA 45.7b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of August 29, 2026, the stock is trading at USD 30.52 with a total of 15,844,562 shares traded. Over the past week, the price has changed by +2.73%, over one month by +7.88%, over three months by +23.52% and over the past year by +13.18%.
Current recommended Stop Loss: 28.70 (which is 6% or 1.3 ATR below the current price).
HP has received a consensus analysts rating of 3.24. Therefore, it is recommended to hold HPQ.
- StrongBuy: 2
- Buy: 2
- Hold: 12
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 27.3 | -10.5% |
P/E Trailing = 11.3092
P/E Forward = 10.0402
P/S = 0.4654
P/B = 0.6074
P/EG = 25.0987
Revenue TTM = 59.2b USD
EBIT TTM = 3.34b USD
EBITDA TTM = 4.25b USD
Long Term Debt = 8.82b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.29b USD (from shortTermDebt, last quarter)
Debt = 10.4b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.20b
Net Debt = 6.19b USD (calculated: Debt 10.4b - CCE 4.17b)
Enterprise Value = 32.9b USD (26.7b + Debt 10.4b - CCE 4.17b)
Interest Coverage Ratio = 6.60 (Ebit TTM 3.34b / Interest Expense TTM 506.0m)
EV/FCF = 8.48x (Enterprise Value 32.9b / FCF TTM 3.88b)
FCF Yield = 11.79% (FCF TTM 3.88b / Enterprise Value 32.9b)
FCF Margin = 6.56% (FCF TTM 3.88b / Revenue TTM 59.2b)
Net Margin = 4.14% (Net Income TTM 2.45b / Revenue TTM 59.2b)
Gross Margin = 19.87% ((Revenue TTM 59.2b - Cost of Revenue TTM 47.4b) / Revenue TTM)
Gross Margin QoQ = 18.79% (prev 20.93%)
Tobins Q-Ratio = 0.72 (Enterprise Value 32.9b / Total Assets 45.7b)
Interest Expense / Debt = 4.89% (Interest Expense 506.0m / Debt 10.4b)
Taxrate = 12.34% (345.0m / 2.80b)
NOPAT = 2.93b (EBIT 3.34b * (1 - 12.34%))
Current Ratio = 0.79 (Total Current Assets 26.7b / Total Current Liabilities 34.0b)
Debt / Equity = 2.68 (Debt 10.4b / totalStockholderEquity, last quarter 3.87b)
Debt / EBITDA = 1.45 (Net Debt 6.19b / EBITDA 4.25b)
Debt / FCF = 1.59 (Net Debt 6.19b / FCF TTM 3.88b)
Total Stockholder Equity = 653.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.73% (Net Income 2.45b / Total Assets 45.7b)
RoE = 375.1% (Net Income TTM 2.45b / Total Stockholder Equity 653.5m)
RoCE = 35.24% (EBIT 3.34b / Capital Employed (Equity 653.5m + L.T.Debt 8.82b))
RoIC = 29.06% (NOPAT 2.93b / Invested Capital 10.1b)
WACC = 7.91% (E(26.7b)/V(37.1b) * Re(9.32%) + D(10.4b)/V(37.1b) * Rd(4.89%) * (1-Tc(0.12)))
Discount Rate = 9.32% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.22 | Cagr: -2.88%
[DCF] Terminal Value 77.97% ; FCFF base≈3.47b ; Y1≈3.97b ; Y5≈5.85b
[DCF] Fair Price = 90.71 (EV 88.0b - Net Debt 6.19b = Equity 81.8b / Shares 901.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -27.29 | EPS CAGR: -0.96% | SUE: 1.23 | # QB: 3
Revenue Correlation: 89.41 | Revenue CAGR: 3.46% | SUE: 4.0 | # QB: 3
EPS current Quarter (2027-01-31): EPS=0.68 | Chg30d=-0.53% | Revisions=-8% | Analysts=11
EPS current Year (2026-10-31): EPS=3.04 | Chg30d=+0.72% | Revisions=-25% | GrowthEPS=-2.6% | GrowthRev=+4.4%
EPS next Year (2027-10-31): EPS=3.00 | Chg30d=-0.38% | Revisions=-25% | GrowthEPS=-1.4% | GrowthRev=+0.0%
[Analyst] Revisions Ratio: -21% (up=4, down=7)